Content focuses on the financial impact of data management systems on drug development, manufacturing, and distribution; the basic computer system life cycle model and the activities and software quality assurance practices in each phase; and the controls and methods necessary to maintain data integrity and security.
Guidance Documents
Advanced Manufacturing (1)
+Artificial Intelligence (1)
+Commissioning & Qualification (1)
+Data Integrity (15)
+GAMP® (14)
+Knowledge Management (1)
+Pharma 4.0™ (1)
+Regulatory (1)
+Validation (10)
+Community Discussions
Community Discussions
Mar 28, 2025
Information Systems
Regulatory
Advanced Manufacturing
Artificial Intelligence
Mar 20, 2025
Sustainable Facilities, HVAC, & Controlled Environments
Mar 20, 2025
Mar 20, 2025
Mar 20, 2025
Data Integrity
Mar 14, 2025
Advanced Manufacturing
Critical Utilities
Pharmaceutical Engineering Magazine Articles
White Papers
January / February 2025
GAMP® is indispensable for safeguarding the safety, quality, and compliance of pharmaceutical…
January / February 2024
Stakeholders across industries are becoming accustomed to using information technology (IT) systems…
March / April 2022
This article aims to refresh information on open-source software (OSS) within regulated computerized…

Webinars
Upcoming
On-Demand
None Available
ISPE in the News
Latest
-
Coming Soon and Recently Published ISPE Guidance Documents
-
Pharmaceutical Compounding: A US FDA Perspective
-
Mexico to Recognize GMP Certifications from North, South American Authorities
-
UK Launches Monthly Bulletins on Device, Drug Safety
-
Inside Africa's Plan to Produce Vaccines Locally
-
Pharma Companies Developing Protein Interaction Prediction Model
-
CDMO Building 2nd Manufacturing Facility in Portugal
-
Flexible Robot can Automate Medical Device Manufacturing
-
New Method May Improve CHO Efficiency
- How Digital Shadows Can Enhance Downstream Processing